10.38
price down icon1.61%   -0.17
after-market Dopo l'orario di chiusura: 10.36 -0.02 -0.19%
loading

Relay Therapeutics Inc Azioni (RLAY) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
7.00
- 0.677 7.679 -
Operating Expenses
15.87%
67.63
80.39 77.52 92.55 84.98
Benefits Costs and Expenses
-
- - - -
Costs And Expenses
15.87%
67.63
80.39 77.52 92.55 84.98
Operating Income/Loss
24.58%
-60.63
-80.39 -76.85 -84.87 -84.98
Income/Loss From Continuing Operations Before Tax
109.44%
7.00
-74.15 -70.38 -77.06 -
Income/Loss From Continuing Operations After Tax
25.97%
-54.89
-74.15 -70.38 -77.06 -76.00
Net Income/Loss
25.97%
-54.89
-74.15 -70.38 -77.06 -76.00
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
99.64%
0.6127
172.39 171.26 169.23 8.2161
Basic Earnings Per Share
27.91%
-0.31
-0.43 -0.41 -0.46 -0.42
Diluted Earnings Per Share
27.91%
-0.31
-0.43 -0.41 -0.46 -0.42
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Capitalizzazione:     |  Volume (24 ore):